Annexin A13 Antibodies

Santa Cruz Biotechnology delivers a wide array of Annexin A13 monoclonal antibodies for research focused on understanding this important protein. Annexin A13 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Annexin A13 is a member of the annexin family, known for its role in cellular processes such as membrane trafficking, apoptosis, and inflammation. Annexin A13 participates in the regulation of calcium-dependent phospholipid binding, which is crucial for maintaining cellular homeostasis and signaling pathways. Research has shown that Annexin A13 plays a significant role in various physiological and pathological conditions. Understanding Annexin A13 function is essential for advancing knowledge about various diseases, including cancer and neurodegenerative disorders. Investigating Annexin A13 expression patterns can provide valuable information about cellular responses and disease progression. Exploring the molecular mechanisms of Annexin A13 helps reveal its impact on cellular function and disease development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Annexin A13 and its role in human health and disease.